#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	15108	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2606	710.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1687	1687	C	962	C,G,A	960,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26502	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4374	756.7	0	.	n	.	0	T695C	SNP	695	695	T	1417	1417	C	939	C,A,T,G	935,2,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26502	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4374	756.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	2059	2059	A	1023	A	1023	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26502	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4374	756.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2693	2693	C	925	C	925	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26502	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4374	756.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2767	2767	A	858	A,C	856,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26502	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4374	756.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3319	3319	C	928	C,G,A	926,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26502	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4374	756.7	0	HET	.	.	.	C2861T,G,A	.	2861	2861	C	3583	3583	C	1048	C,T,G,A	794,250,3,1	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	27	2126	folP	852	852	100.0	folP.l15.c4.ctg.1	2166	122.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1314	1316	AGC	199;199;202	A;G;C	199;199;202	folP.WHO_Z_01426c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5506	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3915	175.3	1	SNP	p	S91F	0	.	.	271	273	TCC	832	834	TCC	215;217;217	T,C,G;C,A;C	212,2,1;216,1;217	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5506	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3915	175.3	1	SNP	p	D95N	0	.	.	283	285	GAC	844	846	GAC	227;227;226	G;A;C	227;227;226	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5506	gyrA	2751	2751	100.0	gyrA.l6.c30.ctg.1	3915	175.3	1	SNP	p	D95G	0	.	.	283	285	GAC	844	846	GAC	227;227;226	G;A;C	227;227;226	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	2242	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1995	140.3	1	SNP	p	G45D	0	.	.	133	135	GGC	778	780	GGC	255;257;257	G;G;C	255;257;257	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1108	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1576	87.2	0	.	n	.	0	A197.	DEL	197	197	A	904	904	A	209	A	209	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5168	parC	2304	2304	99.83	parC.l6.c4.ctg.1	3522	183.2	1	SNP	p	D86N	0	.	.	256	258	GAC	829	831	GAC	225;225;225	G,A;A;C,T	224,1;225;224,1	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5168	parC	2304	2304	99.83	parC.l6.c4.ctg.1	3522	183.2	1	SNP	p	S88P	0	.	.	262	264	TCC	835	837	TCC	225;225;226	T,G;C,G;C	224,1;224,1;226	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4456	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3138	177.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1810	1812	GGC	233;231;232	G;G;C	233;231;232	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3021	169.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1587	1589	GCA	243;241;239	G;C;A,T	243;241;238,1	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3021	169.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1590	1592	ATC	236;234;237	A;T,A;C	236;233,1;237	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3021	169.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1602	1604	GTG	233;232;232	G;T;G	233;232;232	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3021	169.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1602	1604	GTG	233;232;232	G;T;G	233;232;232	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3021	169.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2106	2108	ACC	205;203;202	A,C;C;C,T	203,1;202;199,2	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3021	169.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2160	2162	GCG	207;207;207	G,C;C,A;G	206,1;206,1;207	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3021	169.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2160	2162	GCG	207;207;207	G,C;C,A;G	206,1;206,1;207	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3021	169.6	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2283	2285	GGC	237;237;240	G;G,C;C,T	237;236,1;239,1	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3021	169.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2292	2294	GGC	243;246;247	G;G;C,A	243;246;246,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c4.ctg.1	3021	169.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2310	2312	CCG	223;225;224	C,G;C,G;G	221,2;224,1;224	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5582	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3542	196.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1869	1871	CCG	234;236;235	C,G;C,A;G	232,2;235,1;235	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2622	porA	1146	1146	99.83	porA.l6.c17.ctg.1	2448	133.7	0	.	p	.	0	S22G	NONSYN	64	66	AGC	776	778	GGC	168;166;166	G;G;C	168;166;166	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2622	porA	1146	1146	99.83	porA.l6.c17.ctg.1	2448	133.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	958	958	C	178	C	178	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	298	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1048	27.4	0	.	p	.	0	H217N	NONSYN	649	651	CAT	786	788	AAT	1;1;1	A;A;T	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	298	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1048	27.4	0	.	p	.	0	D218N	NONSYN	652	654	GAT	789	791	AAT	1;1;1	A;A;T	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	298	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1048	27.4	0	.	p	.	0	A222V	NONSYN	664	666	GCT	801	803	GTT	1;1;1	G;T;T	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	298	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1048	27.4	0	.	p	.	0	V226A	NONSYN	676	678	GTA	813	815	GCA	1;1;2	G;C;A	1;1;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	298	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1048	27.4	0	.	p	.	0	.	MULTIPLE	700	702	ACT	836	838	GTA	1;1;2	G;T;A	1;1;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	298	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1048	27.4	0	.	p	.	0	N237K	NONSYN	709	711	AAC	845	847	AAA	2;2;2	A;A;A	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	298	porB1a	984	287	90.38	porB1a.l6.c30.ctg.1	1048	27.4	0	.	p	.	0	D238fs	FSHIFT	712	712	G	848	848	G	2	G	2	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2880	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1746	198.9	0	.	p	.	0	A26T	NONSYN	76	78	GCC	644	646	ACC	253;255;253	A;C,A;C,G	253;254,1;252,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2880	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1746	198.9	0	.	p	.	0	D41K	NONSYN	121	123	GAC	689	691	AAA	233;231;228	A;A,G;A	233;230,1;228	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2880	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1746	198.9	1	SNP	p	G120K	1	G120K	NONSYN	358	360	GGC	926	928	AAG	254;253;253	A;A,T,G;G,A	254;251,1,1;252,1	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2880	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1746	198.9	0	.	p	.	0	R257K	NONSYN	769	771	AGG	1337	1339	AAG	241;245;243	A;A;G	241;245;243	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2880	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1746	198.9	0	.	p	.	0	A323V	NONSYN	967	969	GCC	1535	1537	GTC	201;203;203	G,C;T;C	200,1;203;203	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2880	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1746	198.9	1	SNP	p	A121D	1	.	.	361	363	GAC	929	931	GAC	255;254;254	G;A,C;C	255;253,1;254	porB1b.WHO_P_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2880	porB1b	1047	1047	98.95	porB1b.l15.c30.ctg.1	1746	198.9	1	SNP	p	D121N	0	.	.	361	363	GAC	929	931	GAC	255;254;254	G;A,C;C	255;253,1;254	porB1b.WHO_P_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9580	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5540	215.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1530	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1637	116.5	1	SNP	p	V57M	1	.	.	169	171	ATG	812	814	ATG	282;286;286	A;T;G,A	282;286;285,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
